{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:45:00Z","timestamp":1771328700666,"version":"3.50.1"},"reference-count":52,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Background and Aims: Stroke is the leading cause of seizures and epilepsy in adults; however, current guidelines lack robust recommendations for treating post-stroke seizures (PSSs) and epilepsy (PSE). This study aims to demonstrate the long-term safety and efficacy of lacosamide combined with non-vitamin K antagonist oral anticoagulants (NOACs) in patients with PSE and atrial fibrillation (AF). Methods: In this prospective longitudinal single-center study, 53 patients with concomitant PSE and AF, admitted between 2022 and 2023, received NOACs for AF management and lacosamide for seizure control. A control group of 53 patients with cardioembolic stroke, receiving NOACs (but without PSE), was matched by age, sex, and NIHSS scores to ensure comparability. Results: Over 24 months, 16 patients in the study group and 15 in the control group experienced new embolic events, with no significant difference between groups (p = 0.82). Seizure control improved significantly in the study group, with reduced frequency and severity. No severe adverse events from lacosamide were observed. Conclusions: The combination of NOACs and lacosamide is a safe and effective treatment for patients with AF and PSE and does not increase the risk of recurrent ischemic or hemorrhagic events. Further studies with larger sample sizes and longer follow-ups are needed to confirm these findings and optimize treatment protocols.<\/jats:p>","DOI":"10.3390\/jpm14121125","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T11:26:08Z","timestamp":1732706768000},"page":"1125","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Long-Term Safety and Efficacy of Lacosamide Combined with NOACs in Post-Stroke Epilepsy and Atrial Fibrillation: A Prospective Longitudinal Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4473-2807","authenticated-orcid":false,"given":"Marilena","family":"Mangiardi","sequence":"first","affiliation":[{"name":"Department of Stroke Unit, San Camillo-Forlanini Hospital, 00152 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca Romana","family":"Pezzella","sequence":"additional","affiliation":[{"name":"Department of Stroke Unit, San Camillo-Forlanini Hospital, 00152 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Cruciani","sequence":"additional","affiliation":[{"name":"Unit of Neurology, Neurophysiology, Neurobiology, Department of Medicine, Campus Bio-Medico University, 00128 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Alessiani","sequence":"additional","affiliation":[{"name":"Neurology Division S. Maria Goretti Hospital, 04100 Latina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4401-1695","authenticated-orcid":false,"given":"Sabrina","family":"Anticoli","sequence":"additional","affiliation":[{"name":"Department of Stroke Unit, San Camillo-Forlanini Hospital, 00152 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"18-e3","DOI":"10.1111\/ene.13813","article-title":"Stroke-related epilepsy","volume":"26","author":"Feyissa","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/jamaneurol.2023.3240","article-title":"Outcomes in patients with poststroke seizures: A systematic review and meta-analysis","volume":"80","author":"Misra","year":"2023","journal-title":"JAMA Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuint.2017.02.002","article-title":"Post-stroke epilepsy","volume":"107","author":"Tanaka","year":"2017","journal-title":"Neurochem. Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1684\/epd.2020.1159","article-title":"How to diagnose and treat post-stroke seizures and epilepsy","volume":"22","author":"Zelano","year":"2020","journal-title":"Epileptic Disord."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Tr\u00f6scher, A.R., Gruber, J., Wagner, J.N., B\u00f6hm, V., Wahl, A.S., and von Oertzen, T.J. (2021). Inflammation Mediated Epileptogenesis as Possible Mechanism Underlying Ischemic Post-stroke Epilepsy. Front. Aging Neurosci., 13.","DOI":"10.3389\/fnagi.2021.781174"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Altman, K., Shavit-Stein, E., and Maggio, N. (2019). Post Stroke Seizures and Epilepsy: From Proteases to Maladaptive Plasticity. Front. Cell Neurosci., 13.","DOI":"10.3389\/fncel.2019.00397"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1083\/jcb.200708213","article-title":"Important role of matrix metalloproteinase 9 in epileptogenesis","volume":"180","author":"Wilczynski","year":"2008","journal-title":"J. Cell Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/jnr.23836","article-title":"Prospects of modeling poststroke epileptogenesis","volume":"95","author":"Reddy","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Pijet, B., Kostrzewska-Ksi\u0119zyk, A., Pijet-Kucicka, M., and Kaczmarek, L. (2024). Matrix Metalloproteinase-9 Contributes to Epilepsy Development after Ischemic Stroke in Mice. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25020896"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Yang, H., Song, Z., Yang, G.P., Zhang, B.K., Chen, M., Wu, T., and Guo, R. (2014). The ALDH2 rs671 polymorphism affects post-stroke epilepsy susceptibility and plasma 4-HNE levels. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0109634"},{"key":"ref_11","first-page":"CD005398","article-title":"Antiepileptic drugs for the primary and secondary prevention of seizures after stroke","volume":"2","author":"Chang","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1212\/WNL.0000000000004009","article-title":"Poststroke epilepsy in long-term survivors of primary intracerebral hemorrhage","volume":"88","author":"Lahti","year":"2017","journal-title":"Neurology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"107282","DOI":"10.1016\/j.eplepsyres.2023.107282","article-title":"Post-stroke epilepsy: From clinical predictors to possible mechanisms","volume":"199","author":"Freiman","year":"2024","journal-title":"Epilepsy Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.2147\/NDT.S439995","article-title":"Risk Factors Associated with Epilepsy Related to Cerebrovascular Disease: A Systematic Review and Meta-Analysis","volume":"19","year":"2023","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e209450","DOI":"10.1212\/WNL.0000000000209450","article-title":"Pathophysiology, Diagnosis, Prognosis, and Prevention of Poststroke Epilepsy: Clinical and Research Implications","volume":"102","author":"Tanaka","year":"2024","journal-title":"Neurology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WNP.0b013e3182784729","article-title":"American Clinical Neurophysiology Society\u2019s Standardized Critical Care EEG Terminology: 2012 version","volume":"30","author":"Hirsch","year":"2013","journal-title":"J. Clin. Neurophysiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit Care"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s10548-024-01048-0","article-title":"Functional Connectivity Alterations in Patients with Post-stroke Epilepsy Based on Source-level EEG and Graph Theory","volume":"37","author":"Lee","year":"2024","journal-title":"Brain Topogr."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"\u0160migelskyt\u0117, A., Rimkuvien\u0117, G., \u017dukait\u0117, D., Repe\u010dkait\u0117, G., and Jurkevi\u010dien\u0117, G. (2024). The Association of Epileptic Seizures after Acute Ischemic Stroke with Cerebral Cortical Involvement and Electroencephalographic Changes. Medicina, 60.","DOI":"10.3390\/medicina60050768"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/epi.13448","article-title":"Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors","volume":"57","author":"Ferlazzo","year":"2016","journal-title":"Epilepsia"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1212\/01.wnl.0000281664.02615.6c","article-title":"Electrographic seizures and periodic discharges after intracerebral hemorrhage","volume":"69","author":"Claassen","year":"2007","journal-title":"Neurology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/1086508X.2004.11079478","article-title":"Continuous EEG monitoring in the intensive care unit","volume":"44","author":"Hirsch","year":"2004","journal-title":"Am. J. Electroneurodiagnostic Technol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"fcac312","DOI":"10.1093\/braincomms\/fcac312","article-title":"Interictal epileptiform discharges as a predictive biomarker for recurrence of poststroke epilepsy","volume":"4","author":"Abe","year":"2022","journal-title":"Brain Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/epi4.12103","article-title":"Early EEG predicts poststroke epilepsy","volume":"3","author":"Bentes","year":"2018","journal-title":"Epilepsia Open"},{"key":"ref_25","first-page":"CD005398","article-title":"Antiepileptic drugs for the primary and secondary prevention of seizures after stroke","volume":"1","author":"Sykes","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/1550059419875916","article-title":"Quantitative and quali-tative EEG as a prediction tool for outcome and complicationsin acute stroke patients","volume":"51","author":"Doerrfuss","year":"2020","journal-title":"Clin. EEG Neurosci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.12998\/wjcc.v12.i2.249","article-title":"Electroencephalogram findings in 10 patients with post-stroke epilepsy: A retrospective study","volume":"12","author":"Wen","year":"2024","journal-title":"World J. Clin. Cases"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/2396987317705536","article-title":"European stroke organisation guidelines for the management of post-stroke seizures and epilepsy","volume":"2","author":"Holtkamp","year":"2017","journal-title":"Eur. Stroke J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/jnnp-2015-311849","article-title":"The prognosis of acute symptomatic seizures after ischemic stroke","volume":"88","author":"Leung","year":"2017","journal-title":"J. Neurol. Nerurosurg. Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ryu, H.U., Kim, H.J., Shin, B.S., and Kang, H.G. (2024). Clinical approaches for poststroke seizure: A review. Front. Neurol., 15.","DOI":"10.3389\/fneur.2024.1337960"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e209821","DOI":"10.1212\/WNL.0000000000209821","article-title":"The Adverse Effects of Commonly Prescribed Antiseizure Medications in Adults With Newly Diagnosed Focal Epilepsy","volume":"103","author":"Barnard","year":"2024","journal-title":"Neurology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000342669","article-title":"EPIC study. Levetiracetam versus carbamazepine in patients with late poststroke seizures: A multicenter prospective randomized open-label study (EpIC project)","volume":"34","author":"Consoli","year":"2012","journal-title":"Cerebrovasc. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(21)00247-6","article-title":"The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: An open-label, non-inferiority, multicentre, phase 4, randomised controlled trial","volume":"397","author":"Marson","year":"2021","journal-title":"Lancet"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s40263-023-01052-1","article-title":"Levetiracetam Interaction with Direct Oral Anticoagulants: A Pharmacovigilance Study","volume":"37","author":"Nissan","year":"2023","journal-title":"CNS Drugs"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s40263-024-01077-0","article-title":"The Effect of Levetiracetam Compared with Enzyme-Inducing Antiseizure Medications on Apixaban and Rivaroxaban Peak Plasma Concentrations","volume":"38","author":"Goldstein","year":"2024","journal-title":"CNS Drugs"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Veroniki, A.A., Straus, S.E., and R\u00fccker, G. (2018). Comparative safety and effectiveness of anti-seizure medications for post-stroke seizures: A systematic review and network meta-analysis. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0198447"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/ane.13230","article-title":"Lacosamide in patients with epilepsy of cerebrovascular etiology","volume":"141","author":"Rosenow","year":"2020","journal-title":"Acta Neurol. Scand."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11239-017-1607-9","article-title":"Efficacy and safety of outpatient treatment with direct oral anticoagulation in pulmonary embolism","volume":"45","author":"Ghazvinian","year":"2018","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Pezzella, F.R., Mangiardi, M., Ferrante, M., Fabiano, S., Anticoli, S., Pennacchi, F.G., Urso, A., De Luca, L., and Caso, V. (2022). Management of Oral Anticoagulation and Antiplatelet Therapy in Post-Myocardial Infarction Patients with Acute Ischemic Stroke with and without Atrial Fibrillation. J. Clin. Med., 11.","DOI":"10.3390\/jcm11133894"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s40266-013-0119-3","article-title":"Concerns about the use of new oral anticoagulants for stroke prevention in elderly patients with atrial fibrillation","volume":"30","author":"Finsterer","year":"2013","journal-title":"Drugs Aging"},{"key":"ref_42","first-page":"e38483","article-title":"Treating Post-stroke Epilepsy in a Patient With Multiple Comorbidities","volume":"15","author":"Mangiardi","year":"2023","journal-title":"Cureus"},{"key":"ref_43","first-page":"441","article-title":"The management of epilepsy in the elderly: A critical review","volume":"22","author":"Tomson","year":"2020","journal-title":"Epileptic Disord."},{"key":"ref_44","first-page":"49","article-title":"Optimizing antiseizure medication therapy: Evidence-based recommendations and clinical guidance","volume":"11","author":"Hirsch","year":"2021","journal-title":"Neurol. Clin. Pract."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"102513","DOI":"10.1016\/j.eclinm.2024.102513","article-title":"Efficacy, tolerability and safety of add-on third-generation antiseizure medications in treating focal seizures worldwide: A network meta-analysis of randomised, placebo-controlled trials","volume":"70","author":"Chen","year":"2024","journal-title":"EClinicalMedicine"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Galgani, A., Palleria, C., Iannone, L.F., De Sarro, G., Giorgi, F.S., Maschio, M., and Russo, E. (2018). Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs. Front. Neurol., 9.","DOI":"10.3389\/fneur.2018.01067"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/jamaneurol.2024.2882","article-title":"Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation","volume":"81","author":"Maarse","year":"2024","journal-title":"JAMA Neurol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s40262-013-0087-0","article-title":"Drug interactions with the newer antiepileptic drugs (AEDs)\u2014Part 1: Pharmacokinetic and pharmacodynamics interactions between AEDs","volume":"52","author":"Patsalos","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/epi4.12877","article-title":"Role of the glymphatic system and perivascular spaces as a potential biomarker for post-stroke epilepsy","volume":"9","author":"Hlauschek","year":"2024","journal-title":"Epilepsia Open"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1177\/23969873241244584","article-title":"Exploratory study of blood biomarkers in patients with post-stroke epilepsy","volume":"9","author":"Abraira","year":"2024","journal-title":"Eur. Stroke J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1111\/epi.16648","article-title":"Blood biomarkers predictive of epilepsy after an acute stroke event","volume":"61","author":"Abraira","year":"2020","journal-title":"Epilepsia"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/17425255.2024.2352466","article-title":"Interactions between antiepileptic drugs and direct oral anticoagulants for primary and secondary stroke prevention","volume":"20","author":"Finsterer","year":"2024","journal-title":"Expert. Opin. Drug MetabToxicol."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/14\/12\/1125\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:41:06Z","timestamp":1760114466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/14\/12\/1125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":52,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["jpm14121125"],"URL":"https:\/\/doi.org\/10.3390\/jpm14121125","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]}}}